Frontiers in Endocrinology (Sep 2020)

The Role of hCG Triggering Progesterone Levels: A Real-World Retrospective Cohort Study of More Than 8000 IVF/ICSI Cycles

  • Raffaella De Cesare,
  • Emanuela Morenghi,
  • Federico Cirillo,
  • Camilla Ronchetti,
  • Valentina Canevisio,
  • Paola Persico,
  • Annamaria Baggiani,
  • Maria Teresa Sandri,
  • Paolo Emanuele Levi-Setti

DOI
https://doi.org/10.3389/fendo.2020.547684
Journal volume & issue
Vol. 11

Abstract

Read online

Objective: To assess the association between serum ovulation trigger progesterone (P) levels and the outcome of in vitro fertilization cycles.Design Setting: Real world single-center retrospective cohort study.Patient Intervention(s): All fresh cleavage and blastocyst-stage embryo transfers (ETs) performed from January 2012 to December 2016.Main outcome Measure(s): The impact of premature high serum P levels cycles in terms of clinical pregnancy rates (CPRs) and live birth rates (LBRs).Results: 8,034 ETs were performed: 7,597 cleavage-stage transfers and 437 blastocyst transfers. Serum P levels demonstrated to be inversely related to CPR (OR 0.72, p < 0.001) and LBR (OR 0.73, p < 0.001). The progressive decrease of LBR and CPR started when P levels were >1 ng/ml in a good prognosis cleavage ET subgroup, whereas in patients with worse prognosis only for P ≥ 1.75 ng/ml. In the blastocyst ET subgroup, the negative effect of P elevation was reported only if P was >1.75 ng/ml. CPR (OR 0.71 (0.62–0.80), p < 0.001) and LBR (OR 0.73 (0.63–0.84), p < 0.001) in thawed cycles resulted statistically significantly higher than in fresh cycles in the cleavage-stage subgroup. In the blastocyst group, no significant difference resulted between thawed and fresh cycles, independently of P levels [CPR OR 0. 37 (0.49–1.09), p = 0.123; LBR OR 0.71 (0.46–1.10), p = 0.126].Conclusion: High P levels decrease CPR as well as LBR in both cleavage and blastocyst ET. In the cleavage group, for P levels below 1.75 ng/ml, our data suggest the possibility to wait until day 5 for ET, and if P level is ≥1.75 ng/ml, it should be considered to freeze all embryos and postpone the ET.Clinical Trial Registration:ClinicalTrials.gov, ID: NCT04253470

Keywords